Edgewise Therapeutics Inc (NASDAQ: EWTX) kicked off on Tuesday, up 4.61% from the previous trading day, before settling in for the closing price of $28.20. Over the past 52 weeks, EWTX has traded in a range of $14.90-$38.12.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 5.75%. With a float of $62.40 million, this company’s outstanding shares have now reached $94.41 million.
The extent of productivity of a business whose workforce counts for 88 workers is very important to gauge. In terms of profitability, gross margin is 29.31%, operating margin of -6534.37%, and the pretax margin is -5519.27%.
Edgewise Therapeutics Inc (EWTX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Edgewise Therapeutics Inc is 34.10%, while institutional ownership is 74.16%. The most recent insider transaction that took place on Jan 28 ’25, was worth 690,658. In this transaction CMO of this company sold 25,000 shares at a rate of $27.63, taking the stock ownership to the 16,358 shares. Before that another transaction happened on Jan 28 ’25, when Company’s Officer proposed sale 25,000 for $27.85, making the entire transaction worth $696,250.
Edgewise Therapeutics Inc (EWTX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.16% during the next five years compared to -68.02% drop over the previous five years of trading.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Take a look at Edgewise Therapeutics Inc’s (EWTX) current performance indicators. Last quarter, stock had a quick ratio of 26.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.49, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.87 in one year’s time.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
The latest stats from [Edgewise Therapeutics Inc, EWTX] show that its last 5-days average volume of 0.73 million was inferior to 0.94 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 66.99%. Additionally, its Average True Range was 1.77.
During the past 100 days, Edgewise Therapeutics Inc’s (EWTX) raw stochastic average was set at 59.94%, which indicates a significant decrease from 81.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.56% in the past 14 days, which was lower than the 92.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.09, while its 200-day Moving Average is $23.95. Now, the first resistance to watch is $30.05. This is followed by the second major resistance level at $30.60. The third major resistance level sits at $31.66. If the price goes on to break the first support level at $28.44, it is likely to go to the next support level at $27.38. The third support level lies at $26.83 if the price breaches the second support level.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Key Stats
The company with the Market Capitalisation of 2.79 billion has total of 94,689K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -100,160 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -34,130 K.
